Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
4.040
-0.120 (-2.88%)
At close: Sep 25, 2026, 4:00 PM EDT
4.150
+0.110 (2.72%)
After-hours: Sep 25, 2026, 5:06 PM EDT
Zura Bio Market Cap
Zura Bio has a market cap or net worth of $387.15 million as of September 25, 2026. Its market cap has increased by 160.02% in one year.
Market Cap
387.15M
Enterprise Value
182.02M
1-Year Change
160.02%
Ranking
Category
Stock Price
$4.04
ChartMarket Cap Chart
Since September 3, 2021, Zura Bio's market cap has increased from $167.33M to $387.15M, an increase of 131.38%. That is a compound annual growth rate of 18.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 387.15M | 13.63% |
| Dec 31, 2025 | 340.72M | 108.73% |
| Dec 31, 2024 | 163.23M | -19.82% |
| Dec 29, 2023 | 203.58M | 15.59% |
| Dec 30, 2022 | 176.12M | 3.44% |
| Dec 31, 2021 | 170.26M | 1.75% |
| Sep 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Prelude Therapeutics | 401.17M |
| Editas Medicine | 400.08M |
| Opus Genetics | 398.09M |
| Galectin Therapeutics | 395.83M |
| Arcturus Therapeutics Holdings | 392.95M |
| Agenus | 386.05M |
| Turn Therapeutics | 382.18M |
| Inhibikase Therapeutics | 379.63M |